Recurrent Extradural Myxopapillary Ependymoma With Oligometastatic Spread
Related Experiment Video
Updated: Jan 1, 2026

Role of Diffusion MRI Tractography in Endoscopic Endonasal Skull Base Surgery
Published on: July 5, 2021
Kristen A Batich1,2,3, Richard F Riedel2,4, John P Kirkpatrick3,4,5,6
1Department of Medicine, Duke University Health System, Durham, NC, United States.
Abstract:
Myxopapillary ependymomas are a slow-growing, grade I type glial tumor in the lumbosacral region. More rarely, they can present as extradural, subcutaneous sacrococcygeal, or perisacral masses, and it is under these circumstances that they are more likely to spread. Here, we report the presentation of a sacrococcygeal mass in patient that was initially resected confirming extradural myxopapillary ependymoma. At initial resection, multiple small pulmonary nodules were detected. This mass recurred 2 years later at the resection site with an interval increase in the previously imaged pulmonary nodules. Resection of both the post-sacral mass and largest lung metastasis confirmed recurrent myxopapillary ependymoma with oligometastatic spread. Because these tumors are rare, with extradural presentation being even more infrequent, to this date there are no definitive therapeutic guidelines for initial treatment and continued surveillance. For myxopapillary ependymoma, current standard of care is first-line maximal surgical resection with or without postoperative radiotherapy depending on the extent of disease and extent of resection. However, there remains insufficient evidence on the role of radiotherapy to oligometastatic foci in providing any further survival benefit or extending time to recurrence. Thus, prospective studies assessing the role of upfront treatment of oligometastases with local resection and adjuvant radiotherapy are needed for improved understanding of extradural myxopapillary ependymoma.
Insights
Extradural myxopapillary ependymomas, rare tumors, can spread to distant sites like the lungs. This case highlights the need for further research into treating these rare tumors and their metastases.
Area of Science:
- Neuro-oncology
- Spinal cord tumors
Background:
- Myxopapillary ependymomas are typically slow-growing, Grade I glial tumors found in the lumbosacral region.
- Extradural and subcutaneous sacrococcygeal or perisacral presentations are rare but associated with a higher risk of spread.
Observation:
- A patient presented with a sacrococcygeal mass confirmed as extradural myxopapillary ependymoma.
- Pulmonary nodules were detected at initial resection and increased in size with tumor recurrence at the resection site two years later.
- Recurrent tumor with oligometastatic spread to the lungs was confirmed.
Findings:
- This case demonstrates extradural myxopapillary ependymoma recurrence with oligometastatic spread.
- Current treatment involves maximal surgical resection, with or without radiotherapy, but lacks definitive guidelines for extradural or metastatic disease.
- Evidence is insufficient regarding the benefit of radiotherapy for oligometastatic foci in extending survival or time to recurrence.
Implications:
- Definitive therapeutic guidelines for extradural myxopapillary ependymoma and its metastases are lacking due to rarity.
- Prospective studies are needed to evaluate the efficacy of upfront treatment for oligometastases, including local resection and adjuvant radiotherapy.
- Improved understanding of extradural myxopapillary ependymoma management is crucial for better patient outcomes.
More Related Videos
07:17A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
Published on: January 29, 2021
08:17Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016